See today's BioWorld MedTechSee today's BioWorld
To read the full story, subscribe or sign in.

Mallinckrodt wins FDA nod for regenerative skin therapy for burns

June 16, 2021
By Jennifer Boggs
More than four months after its original PDUFA date of Feb. 2, 2021, Mallinckrodt plc’s Stratagraft gained FDA approval for use in deep partial-thickness thermal burns.
BioWorld BioWorld MedTech Drugs Medical devices and technologies Regulatory Dermatologic BARDA FDA Priority review